Eli Lilly and Company and T1D Exchange have entered into a research collaboration to discover new ways to improve care and advance outcomes for patients with type 1 diabetes (T1D).
The collaboration will include multiple projects over an initial five-year period. It will allow the two firms to gain deeper, real-world insight about the experience of these patients.
Go deeper with GlobalData
Under the deal, both firms will engage in a range of projects that combine Lilly’s expertise in type 1 diabetes with T1D Exchange’s new patient-centric model that connects a clinic registry of more than 26,000 people with T1D and Glu, a patient and caregiver online community for T1D.
Lilly Diabetes medical fellow Dara Schuster said: "Having access to the resources of T1D Exchange to bolster our understanding of the needs of people with type 1 diabetes, their caregivers and health care providers will help us continue our mission of addressing the global diabetes burden through the development of innovative medicines and programmes."
The companies’ first project of the collaboration will evaluate how children and adults with T1D manage the disease over time with insulin pumps and multiple daily injections.
See Also:
Primarily, T1D Exchange data will be analysed to inform development of a survey of health care providers from the clinic network and members of the Glu community.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataAfter the survey, a trial of clinic registry participants is planned, to further analyse how insulin pumps are used and how multiple daily injections occur in real-world practice.
Following completion of the analysis, data and recommendations from the research will be shared publicly to benefit both T1D and researcher communities.
T1D Exchange Clinic Coordinating Center director Roy Beck said the T1D Exchange Clinic Registry was established to provide real-world data on a large number of children and adults with type 1 diabetes to serve as a resource for both academic and company researchers.
"This collaboration with Lilly is a great example of how the registry data can be used to address key issues that are important to individuals with type 1 diabetes," Beck said.
Image: Research projects will use real-world evidence to support people living with type 1 diabetes. Photo: courtesy of Freedigitalphotos.net.
